Company offers 1.3 million units with warrants at $0.50 per unit
By Devika Patel
Knoxville, Tenn., April 16 - Trovagene Inc. settled a $650,000 private placement of units on April 13, according to an 8-K filed Monday with the Securities and Exchange Commission.
The company sold 1.3 million units of one common share and one warrant at $0.50 per unit. Each warrant is exercisable at $0.50 until Dec. 31, 2018. The strike price reflects a 33.33% discount to the April 12 closing share price of $0.75.
Trovagene is a molecular diagnostic company in San Diego.
| Issuer: | Trovagene Inc.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | $650,000
|
| Units: | 1.3 million
|
| Price: | $0.50
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Dec. 31, 2018
|
| Warrant strike price: | $0.50
|
| Settlement date: | April 13
|
| Stock symbol: | Pink Sheets: TROV
|
| Stock price: | $0.75 at close April 12
|
| Market capitalization: | $48.35 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
